Black Rock Inc. Kodiak Sciences Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,858,621 shares of KOD stock, worth $9.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,858,621

Previous 4,032,822 4.32%

Holding current value

$9.07 Million

Previous $12.3 Million 65.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.01 - $7.45 $524,345 - $1.3 Million	-174,201 Reduced 4.32%	3,858,621 $20.3 Million
Q4 2023 Feb 13, 2024	SELL	$1.4 - $3.24 $614,422 - $1.42 Million	-438,873 Reduced 9.81%	4,032,822 $12.3 Million
Q3 2023 Nov 13, 2023	SELL	$1.8 - $7.49 $64,339 - $267,722	-35,744 Reduced 0.79%	4,471,695 $8.05 Million
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $393,669 - $867,903	91,551 Added 2.07%	4,507,439 $31.1 Million
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $616,059 - $1.14 Million	128,079 Added 2.99%	4,415,888 $27.4 Million

Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $1.13 Million - $1.4 Million	174,046 Added 4.23%	4,287,809 $30.7 Million
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $93,050 - $153,650	-12,292 Reduced 0.3%	4,113,763 $31.8 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.48 $3.48 Million - $6.54 Million	690,095 Added 20.08%	4,126,055 $31.5 Million
Q1 2022 May 12, 2022	BUY	$7.09 - $89.45 $4.15 Million - $52.3 Million	584,762 Added 20.51%	3,435,960 $26.5 Million
Q4 2021 Feb 10, 2022	BUY	$80.85 - $128.49 $19.4 Million - $30.8 Million	239,749 Added 9.18%	2,851,198 $242 Million
Q3 2021 Nov 09, 2021	BUY	$81.97 - $106.94 $199,351 - $260,078	2,432 Added 0.09%	2,611,449 $251 Million
Q2 2021 Aug 11, 2021	BUY	$77.2 - $126.54 $201 Million - $330 Million	2,609,017 New	2,609,017 $243 Million

Others Institutions Holding KOD

# of Institutions

112

Shares Held

43M

Call Options Held

87.8K

Put Options Held

7.3K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $122M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account